Behavioral Responses of Heterodera rostochiensis Larvae to Aldicarb and its Sulfoxide and Sulfone
AbstractTemikÖ aldicarb pesticide [2-Methyl-2-(methylthio) propionaldehyde-O-(methylcarbamoyl) oxime] is an effective contact and systemic compound against a wide variety of agricultural pests. Its metabolism in soils may lead to aldicarb sulfoxide and aldicarb sulfone which are both toxicologically important. The comparative effects of these compounds on body activity and stylet movement of second-stage larvae of the potato cyst nematode, Heterodera rostochiensis, were investigated. Temik aldicarb was the most effective contact toxicant, rapidly inhibiting body activity and stimulating abnormal stylet movement. A 24-hr post-nematicide water treatment allowed effective recovery of body vigor and cessation of abnormal stylet movement of the larvae treated with Temik aldicarb at low concentrations, and with aldicarb sulfoxide and aldicarb sulfone at all the dosage levels used. Larvae treated with 10 ppm Temik aldicarb remained paralyzed, the toxic effect being apparently irreversible. Control of Heterodera rostochiensis by direct contact toxicity may not be effective in soil since Temik degrades to compounds having reversible toxic effect. Key Words: Heterodera rostochiensis. Golden nematode, Potato cyst nematode, Aldicarb, Nematicide, 2-Methyl-2-(methylthio) propionaldehyde-O-(methylcarbamoyl)oxime, Toxicity.
Copyright and Permissions
All material published by the Society of Nematologists (SON), except for papers prepared by United States and Canadian government employees, is copyrighted and protected under the U.S. copyright law. Under the Copyright Act of 1976, the term of copyright for materials registered by an organization is 75 years from the date first published. Before publishing any manuscript, SON requires that authors transfer full and complete ownership of any copyright to SON by signing a JON Page Charge/Copyright Form (.pdf). SON then registers the copyright. Subsequent use of published materials requires written permission from the SON and may be obtained by contacting the current Editor-in-Chief and state where and how the material will be used.
The author warrants that the article is an original work not published elsewhere in whole or in part, except in abstract form, and that the author has full power to make this grant. If portions of the article have been published previously, then the author warrants that permission has been obtained from the copyright holder and the author will submit a copy of the permission release with this copyright transfer form.
SON shall claim no proprietary right other than copyright. Authors and coauthors retain the right to revise, adapt, modify, or otherwise use all or part of the article in future works of the author(s), such as press releases, lectures, and reviews, provided that all such use is for the personal noncommercial benefit of the author(s). All patent rights are retained by the author(s).